These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2052328)

  • 41. Physical compatibility of antithymocyte globulin (rabbit) with heparin sodium and hydrocortisone sodium succinate.
    Trissel LA; Saenz CA
    Am J Health Syst Pharm; 2003 Aug; 60(16):1650-2. PubMed ID: 12966908
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of hydrocortisone sodium succinate on voltage-gated sodium current in trigeminal ganglion neurons of rat.
    Li H; Hui F; Jianmin X
    Neurol Res; 2011 Apr; 33(3):295-9. PubMed ID: 21513649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Compatibility of mephentermine sulfate with hydrocortisone sodium succinate or aminophylline in 5% dextrose injection.
    Jhunjhunwala VP; Bhalla HL
    Am J Hosp Pharm; 1981 Dec; 38(12):1922-4. PubMed ID: 7325174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use.
    Bottenberg P; Cleymaet R; de Muynck C; Remon JP; Coomans D; Michotte Y; Slop D
    J Pharm Pharmacol; 1991 Jul; 43(7):457-64. PubMed ID: 1682457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design and in vitro/in vivo evaluation of sustained-release floating tablets of itopride hydrochloride.
    Ahmed SM; Ahmed Ali A; Ali AM; Hassan OA
    Drug Des Devel Ther; 2016; 10():4061-4071. PubMed ID: 28008229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rosin nanoparticles as a drug delivery carrier for the controlled release of hydrocortisone.
    Lee CM; Lim S; Kim GY; Kim DW; Rhee JH; Lee KY
    Biotechnol Lett; 2005 Oct; 27(19):1487-90. PubMed ID: 16231221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of comonomer ratio on hydrocortisone diffusion from sustained-release composite capsules.
    Fu JC; Moyer DL; Hagemeier C
    J Biomed Mater Res; 1978 May; 12(3):249-54. PubMed ID: 670251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A unified mathematical model for diffusion from drug-polymer composite tablets.
    Fu JC; Hagemeir C; Moyer DL
    J Biomed Mater Res; 1976 Sep; 10(5):743-58. PubMed ID: 977604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrasonically mediated solute permeation through polymer barriers.
    Julian TN; Zentner GM
    J Pharm Pharmacol; 1986 Dec; 38(12):871-7. PubMed ID: 2880958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzymatically controlled drug release systems.
    Ratner BD; Horbett TA
    Methods Enzymol; 1985; 112():484-95. PubMed ID: 4046860
    [No Abstract]   [Full Text] [Related]  

  • 51. [Utility of challenge test in immediate hypersensitivity to hydrocortisone sodium succinate].
    Amaya-Mejía AS; Galindo-Pacheco LV; O'Farrill-Romanillos PM; Rodríguez-Mireles KA; Campos-Romero FH; del Rivero-Hernández L
    Rev Alerg Mex; 2014; 61(1):32-7. PubMed ID: 24913000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimization of acyclovir oral tablets based on gastroretention technology: factorial design analysis and physicochemical characterization studies.
    El Gamal SS; Naggar VF; Allam AN
    Drug Dev Ind Pharm; 2011 Jul; 37(7):855-67. PubMed ID: 21401342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of tensides on the release of medical agents from hydrophilic gels, part 2: The influence of selected tensides on hydrocortisone release from xerogels.
    Szcześniak M; Kubis AA
    Pharmazie; 2004 Mar; 59(3):198-9. PubMed ID: 15074592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro and in-vivo characteristics of a modified-release double-pulse formulation for a water soluble drug.
    Avramoff A; Domb AJ
    Int J Clin Pharmacol Ther; 2010 Apr; 48(4):250-8. PubMed ID: 20353746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemical stabilities of hydrocortisone sodium succinate and several antibiotics when mixed with metronidazole injection for intravenous infusion.
    Gupta VD; Stewart KR
    J Parenter Sci Technol; 1985; 39(3):145-9. PubMed ID: 3998970
    [No Abstract]   [Full Text] [Related]  

  • 56. [Development and evaluation of an active substance controlled-release device for use in the oral cavity].
    Diarra M; Pourroy G; Muster D; Zingraff M; Boymond C
    Rev Stomatol Chir Maxillofac; 1998 Jul; 99 Suppl 1():94-8. PubMed ID: 9697239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Preperation of terbutaline sulphate pulsatile release tablet and mechanism elucidation].
    Zhang Y; Zhang ZR
    Yao Xue Xue Bao; 2003 Nov; 38(11):854-8. PubMed ID: 14992001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers.
    Yu DG; Shen XX; Branford-White C; White K; Zhu LM; Bligh SW
    Nanotechnology; 2009 Feb; 20(5):055104. PubMed ID: 19417335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release.
    Efentakis M; Koligliati S; Vlachou M
    Int J Pharm; 2006 Mar; 311(1-2):147-56. PubMed ID: 16436321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mathematical models for the release of drugs from matrix tablets.
    Cobby J
    J Biomed Mater Res; 1978 Sep; 12(5):627-34. PubMed ID: 701299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.